Efficacy and Safety of Sitagliptin in Hispanic/Latino Patients with Type 2 Diabetes: A Pooled Analysis from Ten Randomized, Placebo-Controlled Phase 3 Clinical Trials

INTRODUCTION: To assess the efficacy and safety profile of the dipeptidyl-peptidase-4 inhibitor sitagliptin in a population of self-identified Hispanic/Latino patients with type 2 diabetes. METHODS: Data were pooled from ten randomized, double-blind studies in which subjects were treated with sitagl...

Descripción completa

Detalles Bibliográficos
Autores principales: Raji, Annaswamy, Long, Jianmin, Lam, Raymond L. H., O’Neill, Edward A., Engel, Samuel S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6064579/
https://www.ncbi.nlm.nih.gov/pubmed/29936573
http://dx.doi.org/10.1007/s13300-018-0461-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6064579/
https://www.ncbi.nlm.nih.gov/pubmed/29936573
http://dx.doi.org/10.1007/s13300-018-0461-x

Ejemplares similares